Skip to main content

Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12

  • 2010-05-19
  • Probiotics and Antimicrobial Proteins 2(3)
    • Jeremy P. Burton
    • C. Chilcott
    • P. Wescombe
    • J. Tagg

Abstract

Previous studies of the bacteriocin-producing Streptococcus salivarius K12 monitored a variety of intrinsic strain characteristics of potential relevance to its application as an oral probiotic in humans. These included the content of antibiotic resistance and virulence determinants, the production of deleterious metabolic by-products and its genetic stability. In the present study, we examined additional safety factors including the responses of rats to either short- or long-term oral dosing with strain K12 preparations. In addition, the potential genotoxicity of strain K12 was tested using a bacterial reverse mutation assay. To determine the occurrence and concentrations in human saliva of S. salivarius having the same bacteriocin phenotype as strain K12, saliva samples from 780 children were evaluated. The level of dosing with strain K12 required to achieve oral cavity colonization levels similar to those occurring naturally for this type of bacteriocin-producing S. salivarius was established using 100 human subjects. Following the oral instillation of lyophilized S. salivarius K12 cells in these subjects, its persistence was not at levels higher than those found naturally for this type of bacterium. The various sets of data obtained in this study showed no evidence of genotoxicity and no acute or subacute toxicity effects associated with strain K12. Based on the previously published data, the long history of use by humans and the information presented here, it is concluded that S. salivarius K12 is safe for human consumption.

Keywords: BLIS; Bacteriocins; Probiotics; Safety; Streptococcus salivarius.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Streptococcus salivarius BLIS K12Absence of Acute or Subacute ToxicityNeutral
Moderate
Streptococcus salivarius BLIS K12Absence of GenotoxicityNeutral
Moderate
Streptococcus salivarius BLIS K12Ensured Safety for Human ConsumptionNeutral
Large
Streptococcus salivarius BLIS K12No Adverse Health Effects in Animal StudyNeutral
Moderate
Streptococcus salivarius K12Absence of Acute or Subacute ToxicityNeutral
Moderate
Streptococcus salivarius K12Absence of GenotoxicityNeutral
Moderate
Streptococcus salivarius K12Ensured Safety for Human ConsumptionNeutral
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.